Modig Berndt
Insider CIK 1643072 · AXON Director · PHVS Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 300,000 | $35.00 | $10.50M | 650,000 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 300,000 | $35.00 | $10.50M | 650,000 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-09-14 | 2026-09-15 | 2,291 | $39.40 | $90.3K | 128,334 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-09-14 | 2026-09-15 | 2,291 | $39.40 | $90.3K | 128,334 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-08-14 | 2026-08-18 | 2,292 | $34.77 | $79.7K | 130,625 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-08-14 | 2026-08-18 | 2,292 | $34.77 | $79.7K | 130,625 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-07-13 | 2026-07-15 | 2,292 | $34.97 | $80.2K | 132,917 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-06-15 | 2026-06-17 | 2,191 | $31.05 | $68.0K | 135,309 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-06-15 | 2026-06-17 | 100 | $31.46 | $3.1K | 135,209 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-05-18 | 2026-05-20 | 2,292 | $29.22 | $67.0K | 137,500 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-04-16 | 2026-04-20 | 2,292 | $28.60 | $65.6K | 139,792 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-04-09 | 2026-04-10 | 200 | $28.42 | $5.7K | 142,084 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-04-09 | 2026-04-10 | 23,133 | $27.74 | $641.7K | 142,284 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 42,000 | — | $0 | 42,000 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 255,000 | — | $0 | 255,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-03-15 | 2018-03-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | M Exercise deriv | 2017-12-29 | 2018-01-03 | 77,914 | — | $0 | 7,086 | SEC↗ |
| AXON Axovant Sciences Ltd. | M Exercise | 2017-12-29 | 2018-01-03 | 77,914 | $0.90 | $70.1K | 77,914 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2017-04-28 | 2017-05-02 | 27,000 | — | $0 | 27,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2016-04-29 | 2016-05-03 | 47,000 | — | $0 | 47,000 | SEC↗ |